As was revealed a week ago in a Tesla app decompiling, the EV maker re-launched its Early Access Program. The program is specifically focused on testing Full Self-Driving builds, and so far, invites ...
CHICAGO, October 08, 2025--(BUSINESS WIRE)--Emalex Biosciences today announced that the U.S. Food and Drug Administration has authorized the company’s Expanded Access Program (EAP) for ecopipam, an ...
Cognition Therapeutics, Inc. announced the initiation of an expanded access program (EAP) funded by an anonymous philanthropic donation from the family of a patient with dementia with Lewy bodies (DLB ...
Baylor selects the Nautilus Voyager™ Platform, now available through Early Access Program, for development of a first-in-class computational multi-omics toolkit ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results